- Home
- SKYH vs MRVI Comparison
SKYH vs MRVI Comparison
Compare SKYH & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- MRVI
- Stock Information
- Founded
- SKYH 2017
- MRVI 2014
- Country
- SKYH United States
- MRVI United States
- Employees
- SKYH N/A
- MRVI N/A
- Industry
- SKYH Military/Government/Technical
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- MRVI Health Care
- Exchange
- SKYH Nasdaq
- MRVI Nasdaq
- Market Cap
- SKYH 325.2M
- MRVI 371.8M
- IPO Year
- SKYH N/A
- MRVI 2020
- Fundamental
- Price
- SKYH $10.52
- MRVI $2.42
- Analyst Decision
- SKYH Strong Buy
- MRVI Hold
- Analyst Count
- SKYH 3
- MRVI 10
- Target Price
- SKYH $14.83
- MRVI $5.84
- AVG Volume (30 Days)
- SKYH 104.9K
- MRVI 1.4M
- Earning Date
- SKYH 08-12-2025
- MRVI 08-11-2025
- Dividend Yield
- SKYH N/A
- MRVI N/A
- EPS Growth
- SKYH N/A
- MRVI N/A
- EPS
- SKYH N/A
- MRVI N/A
- Revenue
- SKYH $20,919,000.00
- MRVI $219,830,000.00
- Revenue This Year
- SKYH $124.39
- MRVI N/A
- Revenue Next Year
- SKYH $83.05
- MRVI $7.23
- P/E Ratio
- SKYH N/A
- MRVI N/A
- Revenue Growth
- SKYH 94.38
- MRVI N/A
- 52 Week Low
- SKYH $9.28
- MRVI $1.67
- 52 Week High
- SKYH $14.52
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- SKYH 52.98
- MRVI 49.60
- Support Level
- SKYH $10.20
- MRVI $2.28
- Resistance Level
- SKYH $10.89
- MRVI $2.47
- Average True Range (ATR)
- SKYH 0.40
- MRVI 0.14
- MACD
- SKYH 0.02
- MRVI -0.01
- Stochastic Oscillator
- SKYH 46.43
- MRVI 27.45
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.